The impact of rare EGFR mutations on the treatment response of patients with non-small cell lung cancer.
about
Other targeted drugs in melanomaComparison of the effectiveness of erlotinib, gefitinib, and afatinib for treatment of non-small cell lung cancer in patients with common and rare EGFR gene mutations.Driver oncogenes in Sub-Saharan African patients with non-small cell lung cancer.Exon 19 L747P mutation presented as a primary resistance to EGFR-TKI: a case reportPrioritizing molecular markers to test for in the initial workup of advanced non-small cell lung cancer: wants versus needs.
P2860
The impact of rare EGFR mutations on the treatment response of patients with non-small cell lung cancer.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
The impact of rare EGFR mutati ...... th non-small cell lung cancer.
@en
The impact of rare EGFR mutati ...... th non-small cell lung cancer.
@nl
type
label
The impact of rare EGFR mutati ...... th non-small cell lung cancer.
@en
The impact of rare EGFR mutati ...... th non-small cell lung cancer.
@nl
prefLabel
The impact of rare EGFR mutati ...... th non-small cell lung cancer.
@en
The impact of rare EGFR mutati ...... th non-small cell lung cancer.
@nl
P2860
P1476
The impact of rare EGFR mutati ...... th non-small cell lung cancer.
@en
P2093
Miguel Angel Molina-Vila
Niki Karachaliou
P2860
P304
P356
10.1586/17476348.2015.1046439
P577
2015-05-20T00:00:00Z